Faculty
Dr. Alex Surbaugh, from Franklin, Tennessee, a clinical pharmacist in psychiatry, is serving as Assistant Professor in Pharmacy Practice.
She previously came from the University of Kansas Health System, where she completed a PGY1 residency and a PGY2 psychiatric residency. She completed her undergraduate degree in chemistry at the University of Mississippi and earned her PharmD at UT.
Education, Degree, & Post Graduate Training
-
- Bachelor of Science in Chemistry, The University of Mississippi - 2018
- Doctor of Pharmacy, University of Tennessee - 2022
- PGY1 Pharmacy Practice Residency - 2023
- PGY2 Psychiatric Pharmacy Practice Residency - 2024
Research Interests
-
- Substance use disorders
- Perceptions surrounding psychiatry
- Scholarship of teaching and learning
Selected Publications
-
- Wallace L. Medications used for weight loss (associated with psychiatric medications
or psychiatric conditions): Metformin, Topiramate, Ozempic. Consumer Tool for American
Association of Psychiatric Pharmacists. Dec 2023.
- Wallace L. Medications used for weight loss (associated with psychiatric medications
or psychiatric conditions): Metformin, Topiramate, Ozempic. Consumer Tool for American
Association of Psychiatric Pharmacists. Dec 2023.
- Gatwood J, Dashputre A, Rajpurohit A, Gatwood K, Mackler E, Wallace L, Farris K, Rizvi-Toner
A, Farley J. Impact of initiating oral anticancer agents for leukemia on adherence
to medications for multiple chronic conditions. J Oncol Pharm Pract. 2023 Apr 27:10781552231171926.
- Gatwood J, Dashputre A, Rajpurohit A, Gatwood K, Mackler E, Wallace L, Farris K, Rizvi-Toner
A, Farley J. Impact of initiating oral anticancer agents for leukemia on adherence
to medications for multiple chronic conditions. J Oncol Pharm Pract. 2023 Apr 27:10781552231171926.
- Gatwood J, Dashputre A, Rajpurohit A, Gatwood K, Mackler E, Wallace L, Farris K, Rizvi-Toner A, Farley J. Medication Adherence Among Adults With Comorbid Chronic Conditions Initiating Oral Anticancer Agent Therapy for Multiple Myeloma. JCO Oncol Pract. 2022;18:e1475-83.